Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease

Journal of Infectious Diseases

Volumn 173, Issue 1, 1996, Pages 256-258

  Chan, Christina Y ^b   Molrine, Deborah C ^b   George, Suzanne ^b   Tarbell, Nancy J ^b   Mauch, Peter ^b   Diller, Lisa ^b   Shamberger, Robert C ^b   Phillips, Nichole R ^b   Goorin, Amy ^b   Ambrosino, Donna M ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROTYPE; SPLENECTOMY;

EID: 19144372371     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.1.256     Document Type: Article

References (15)

1. Notter DT, Grossman PL, Rosenberg SA, Remington JS. Infections in patients with Hodgkin's disease: a clinical study of 300 consecutive adult patients. Rev Infect Dis 1980;2:761-800.
2. Donaldson SS, Glatstein E, Vosti KL. Bacterial infections in pediatric Hodgkin's disease. Relationship to radiotherapy, chemotherapy, and splenectomy. Cancer 1978;41:1949-58.
3. Chilcote RR, Baehner RL, Hammond D, Investigators and Special Studies Committee of Children's Cancer Study Group. Septicemia and meningitis in children splenectomized for Hodgkin's disease. N Engl J Med 1976;295:798-800.
4. Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis 1981;3(suppl):S184-96.
5. Siber GR, Weitzman SA, Aisenberg AC. Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens. Rev Infect Dis 1981;3(suppl):S144-59.
6. Frederiksen B, Specht L, Henrichsen J, Pedersen FK, Pedersen-Bjergaard J. Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease. Eur J Haematol 1989;43:45-9.
7. Molrine DC, George S, Tarbell N, et al. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines following treatment for Hodgkin's disease. Ann Intern Med (in press).
8. Quataert SA, Quackenbush-Wiedl L, Phipps DC, Madore DV. Quantitation of anti-polysaccharide antibodies in a new human reference serum for Streptococcal pneumoniae [abstract]. Pediatr Res 1993;33:179A.
9. Heidelberger M, MacLeod CM, Kaiser SJ, Robinson B. Antibody formation in volunteers following injection of pneumococci or their type-specific polysaccharides. J Exp Med 1946;83:303-20.
10. Baker PJ, Stashak PW, Amsbaugh DF, Prescott B. Characterization of the antibody response to type III pneumococcal polysaccharide at the cellular level. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response. Immunology 1971;20:469-79.
11. Insel RA, Anderson PW. Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae type b capsular polysaccharide in human infants. J Exp Med 1986;163:262-9.
12. Weinberg GA, Einhorn MS, Lenoir AA, Granoff PD, Granoff DM. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. J Pediatr 1987;111:22-7.
13. Kennedy D, Derousse C, Anderson E. Immunologic response of 12-18 months old children to licensed pneumococcal polysaccharide vaccine primed with Streptococcus pneumoniae 19F conjugate vaccine [abstract]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, FL). Washington, DC: American Society for Microbiology, 1994:236.
14. Kennedy D, Geldmacher K, Anderson E. Immunologic response to licensed pneumococcal polysaccharide vaccine (PS) in infants primed with heptavalent Streptococcus pneumoniae conjugated vaccine [abstract]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, FL). Washington DC: American Society for Microbiology, 1994:236.
15. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. JAMA 1993; 270:1826-31.